Efficacy and safety of factor eight inhibitor bypassing activity prophylaxis evaluation in young patients with hemophilia and high titer inhibitor.
Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mehran
M
Karimi
Hakimeh
H
Tavoosi
Sezaneh
S
Haghpanah
Resvan
R
Ardeshiri
Zohreh
Z
Zahedi
Tahereh
T
Zarei
Nader
N
Cohan
D057134:Antibodies, Neutralizing / Q000097:blood; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006395:Hemarthrosis / Q000097:blood / Q000473:pathology / Q000517:prevention & control*; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D061214:Patient Safety; D016896:Treatment Outcome
D057134:Antibodies, Neutralizing; D001779:Blood Coagulation Factors; D006490:Hemostatics; C065655:anti-inhibitor coagulant complex